2804 Federal Register / Vol. 83, No. 13 / Friday, January 19, 2018 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Office for Civil Rights; Statement of 

Delegation 

In accordance with Executive Order 

13798 Promoting Free Speech and 

Religious Liberty (May 4, 2017), 82 FR 

21675, and the Attorney General’s 

Guidance on Federal Law Protections 

for Religious Liberty (October 6, 2017), 

notice is hereby given that I have 

delegated to the Director of the Office 

for Civil Rights (OCR), or his or her 

successor, authority over 

implementation of and compliance with 

the Religious Freedom Restoration Act 

(RFRA), 42 U.S.C. 2000bb et seq., 

relating to programs or activities 

funded, conducted, or administered by 

the Department. 

Pursuant to this delegation, the OCR 

Director shall have the authority to: 

(1) Accept and investigate complaints 

filed by individuals or entities alleging 

a failure by any departmental 

component to comply with RFRA; 

(2) conduct RFRA compliance reviews 

of departmental programs or activities; 

(3) provide technical assistance to 

departmental components regarding 

RFRA compliance; 

(4) evaluate the effectiveness of RFRA 

complaint processing by OCR and 

provide reports to appropriate oversight 

organizations; and 

(5) initiate such other actions as may 

be necessary to facilitate and ensure 

compliance with RFRA. 

This authority may be redelegated. If 

the OCR Director chooses to redelegate 

this authority, the OCR Director will 

maintain primary responsibility and 

accountability for implementation of 

this section. This delegation is effective 

upon date of signature. I hereby affirm 

and ratify any actions taken by the 

Director of OCR or subordinates which 

involved the exercise of the authorities 

delegated herein prior to the effective 

day of this delegation. 

Dated: December 7, 2017. 

Eric D. Hargan, 

Acting Secretary, Department of Health and 

Human Services. 

[FR Doc. 2018–00816 Filed 1–18–18; 8:45 am] 

BILLING CODE 4153–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Office for Civil Rights; Statement of 

Delegation 

Notice is hereby given that I have 

delegated to the Director of the Office 

for Civil Rights, or his or her successor, 

the authorities vested in the Secretary 

concerning enforcement of and 

compliance with Section 1303(b)(4) of 

the Patient Protection and Affordable 

Care Act, 42 U.S.C. 18023(b)(4). This 

delegation transfers, but only for the 

authorities pursuant to Section 

1303(b)(4) and not for other authorities 

under Section 1303, the previous 

delegation to the Administrator, Centers 

for Medicare & Medicaid Services, or his 

or her successor, noticed at 76 FR 53903 

(Aug. 30, 2011). 

Pursuant to this delegation, the OCR 

Director shall have the authority to: 

(1) Accept and investigate complaints 

filed by individuals or entities alleging 

a failure to comply with Section 

1303(b)(4); 

(2) conduct Section 1303(b)(4) 

compliance reviews; 

(3) provide technical assistance to 

departmental components and qualified 

health plans regarding Section 

1303(b)(4) compliance; 

(4) evaluate the effectiveness of 

subsection 1303(b)(4) complaint 

processing by OCR and provide reports 

to appropriate oversight organizations; 

and 

(5) initiate such other actions as may 

be necessary to facilitate and ensure 

compliance with Section 1303(b)(4). 

This authority may be redelegated. If 

the OCR Director chooses to redelegate 

this authority, the OCR Director will 

maintain primary responsibility and 

accountability for implementation of 

this section. This delegation is effective 

upon date of signature. I hereby affirm 

and ratify any actions taken by the 

Director of OCR or subordinates which 

involved the exercise of the authorities 

delegated herein prior to the effective 

day of this delegation. 

Dated: December 7, 2017. 

Eric D. Hargan, 

Acting Secretary, Department of Health and 

Human Services. 

[FR Doc. 2018–00818 Filed 1–18–18; 8:45 am] 

BILLING CODE 4153–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Cognition and Perception Study 

Section. 

Date: February 8–9, 2018. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Baltimore, Inner 

Harbor, 222 St. Paul Place, Baltimore, MD 

21202. 

Contact Person: Andrea B. Kelly, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3184, 

MSC 7770, Bethesda, MD 20892, (301) 455– 

1761, kellya2@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Adult Psychopathology and Disorders 

of Aging Study Section. 

Date: February 12–13, 2018. 

Time: 8:30 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel at Pentagon City, 

1250 South Hayes Street, Arlington, VA 

22202. 

Contact Person: Serena Chu, Ph.D., 

Scientific Review Officer, BBBP IRG, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3178, 

MSC 7848, Bethesda, MD 20892, (301) 500– 

5829, sechu@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Cellular 

Aspects of Diabetes and Obesity Study 

Section. 

Date: February 13–14, 2018. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel, 1700 Tysons 

Boulevard, McLean, VA 22102. 

Contact Person: Antonello Pileggi, MD, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institute of 


daltland on DSKBBV9HB2PROD with NOTICES